These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32064364)

  • 1. Empowering Clinical Diagnostics with Mass Spectrometry.
    Banerjee S
    ACS Omega; 2020 Feb; 5(5):2041-2048. PubMed ID: 32064364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in mass spectrometry based clinical proteomics: applications to cancer research.
    Macklin A; Khan S; Kislinger T
    Clin Proteomics; 2020; 17():17. PubMed ID: 32489335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry applications in microbiology beyond microbe identification: progress and potential.
    Sanguinetti M; Posteraro B
    Expert Rev Proteomics; 2016 Oct; 13(10):965-977. PubMed ID: 27598407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambient Ionization and Miniature Mass Spectrometry Systems for Disease Diagnosis and Therapeutic Monitoring.
    Zhang W; Wang X; Xia Y; Ouyang Z
    Theranostics; 2017; 7(12):2968-2981. PubMed ID: 28839457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mass spectrometry application for clinical diagnostics chairmen's introductory remarks].
    Saito K; Nomura F
    Rinsho Byori; 2013 Sep; 61(9):803-4. PubMed ID: 24369592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective applications of ultrahigh resolution proteomics in clinical mass spectrometry.
    Ruhaak LR; van der Burgt YE; Cobbaert CM
    Expert Rev Proteomics; 2016 Dec; 13(12):1063-1071. PubMed ID: 27798968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Garg U; Zhang YV
    Methods Mol Biol; 2016; 1383():1-10. PubMed ID: 26660168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics: from basic research to diagnostic application. A review of requirements & needs.
    Vitzthum F; Behrens F; Anderson NL; Shaw JH
    J Proteome Res; 2005; 4(4):1086-97. PubMed ID: 16083257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond (mini review).
    Wieser A; Schneider L; Jung J; Schubert S
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):965-74. PubMed ID: 22198716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALDI-TOF MS as evolving cancer diagnostic tool: a review.
    Rodrigo MA; Zitka O; Krizkova S; Moulick A; Adam V; Kizek R
    J Pharm Biomed Anal; 2014 Jul; 95():245-55. PubMed ID: 24699369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From bench to MS bedside: challenges translating biomarker discovery to clinical practice.
    Rajasekharan S; Bar-Or A;
    J Neuroimmunol; 2012 Jul; 248(1-2):66-72. PubMed ID: 22381245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers.
    Walzl G; McNerney R; du Plessis N; Bates M; McHugh TD; Chegou NN; Zumla A
    Lancet Infect Dis; 2018 Jul; 18(7):e199-e210. PubMed ID: 29580818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in mass spectrometry-based clinical biomarker discovery.
    Crutchfield CA; Thomas SN; Sokoll LJ; Chan DW
    Clin Proteomics; 2016; 13():1. PubMed ID: 26751220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-MALDI-TOF MS: new perspectives for clinical applications of mass spectrometry.
    Sparbier K; Wenzel T; Dihazi H; Blaschke S; Müller GA; Deelder A; Flad T; Kostrzewa M
    Proteomics; 2009 Mar; 9(6):1442-50. PubMed ID: 19235164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of MS-based protein quantification.
    Sabbagh B; Mindt S; Neumaier M; Findeisen P
    Proteomics Clin Appl; 2016 Apr; 10(4):323-45. PubMed ID: 27061318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving cancer diagnostics from bench to bedside.
    Zhang X; Li L; Wei D; Yap Y; Chen F
    Trends Biotechnol; 2007 Apr; 25(4):166-73. PubMed ID: 17316853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a quantitative assay based on tandem mass spectrometry.
    Honour JW
    Ann Clin Biochem; 2011 Mar; 48(Pt 2):97-111. PubMed ID: 21303874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
    Shou WZ; Zhang J
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.